Literature DB >> 19322001

Epididymoorchitis due to Brucella melitensis: review of 19 patients.

H Cem Gul1, Ilker Akyol, Bulent Sen, Cuneyt Adayener, Abdullah Haholu.   

Abstract

INTRODUCTION: We describe the clinical characteristics, treatment and long-term outcome of 19 patients with Brucella epididymoorchitis treated at the Department of Urology.
MATERIALS AND METHODS: Between 1998 and 2005, a total of 19 cases with epididymoorchitis due to Brucella melitensis were diagnosed at our hospital. The diagnosis of Brucella was made by isolating Brucella species from blood culture or epididymal aspiration or by standard tube agglutination testing and slide agglutination testing together with clinical findings.
RESULTS: Seven cases (36.8%) had undulant fever. Brucella species was isolated from blood cultures in 11 patients and from epididymal aspiration in 3 patients. Rose Bengal tests were positive in all patients. Total recovery was obtained in 12 cases with a 6-week treatment. Five patients (26.3%) did not respond to therapy and another 2 (10.5%) relapsed.
CONCLUSIONS: Brucella orchitis should be considered in the differential diagnosis of scrotal pathologies where Brucella is endemic. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19322001     DOI: 10.1159/000200791

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Brucella epididymo-orchitis initially mimicking choledocholithiasis.

Authors:  M Kurt; S Kuran; Y T Tekce; A Sayilir; E Oztas; N Sasmaz
Journal:  Infection       Date:  2011-03-23       Impact factor: 3.553

2.  First report of orchitis in man caused by Brucella abortus biovar 1 in Ecuador.

Authors:  Jorge Ron-Román; Claude Saegerman; Elizabeth Minda-Aluisa; Washington Benítez-Ortíz; Jef Brandt; Richard Douce
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

3.  Comparison of inflammatory markers between brucella and non-brucella epididymo-orchitis.

Authors:  Ali Cift; Mehmet Ozgur Yucel
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.